Low-Dose Cyclophosphamide versus Intermediate-High-Dose Cyclophosphamide versus Granulocyte Colony-Stimulating Factor Alone for Stem Cell Mobilization in Multiple Myeloma in the Era of Novel Agents: A Multicenter Retrospective Study-Reference-Cited by-同舟云学术

Low-Dose Cyclophosphamide versus Intermediate-High-Dose Cyclophosphamide versus Granulocyte Colony-Stimulating Factor Alone for Stem Cell Mobilization in Multiple Myeloma in the Era of Novel Agents: A Multicenter Retrospective Study

Published:2021-03 Issue:3 Volume:27 Page:244.e1-244.e8
ISSN:2666-6367
Container-title:Transplantation and Cellular Therapy
language:en
Short-container-title:Transplantation and Cellular Therapy

Author:

Zannetti Beatrice Anna,Saraceni Francesco,Cellini Claudia,Fabbri Elisabetta,Monaco Federica,Guarini Attilio,Laszlo Daniele,Martino Massimo,Olivieri Attilio,Imola Manuela,Tosi Patrizia,Chiarucci Martina,Zuffa Eliana,Lanza Francesco

Funder

AbbVie

Publisher

Elsevier BV

Subject

Transplantation,Cell Biology,Hematology,Molecular Medicine,Immunology and Allergy

Reference45 articles.

1. Multiple myeloma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up;Moreau;Ann Oncol,2017

2. Management of multiple myeloma in the newly diagnosed patient;Mateos;Hematology Am Soc Hematol Educ Program,2017

3. Autologous transplantation for newly diagnosed multiple myeloma in the era of novel agent induction: a systematic review and meta-analysis;Dhakal;JAMA Oncol,2018

4. Current status of autologous stem cell transplantation for multiple myeloma;Al Hamed;Blood Cancer J,2019

5. Long-term outcomes after autologous stem cell transplantation for multiple myeloma;Nishimura;Blood Adv,2020

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Analysis of apheresis outcomes in a cohort of Chilean patients treated with autologous stem cell transplantation: A single center real-world experience;Transfusion and Apheresis Science;2024-10

2. Mobilization strategies with and without plerixafor for autologous stem cell transplant in patients with multiple myeloma;Bone Marrow Transplantation;2024-07-31

3. Impact of Anti-CD38 Monoclonal Antibody Therapy on CD34+ Hematopoietic Stem Cell Mobilization, Collection, and Engraftment in Multiple Myeloma Patients—A Systematic Review;Pharmaceuticals;2024-07-15

4. Novel approaches for hematopoietic stem cell mobilisation and collection need to be assessed for qualification and validation to accomplish the proper requirements of their intended purpose;Transfusion and Apheresis Science;2024-06

5. Multiple Myeloma: The Role of Autologous Stem Cell Transplantation in the Era of Immunotherapy;Cells;2024-05-16